Lagoda Investment Management L.P. Has $9.41 Million Position in Stereotaxis, Inc. (NYSEAMERICAN:STXS)

Lagoda Investment Management L.P. raised its position in Stereotaxis, Inc. (NYSEAMERICAN:STXS - Free Report) by 7.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 4,126,135 shares of the company's stock after purchasing an additional 295,700 shares during the period. Stereotaxis accounts for 5.1% of Lagoda Investment Management L.P.'s investment portfolio, making the stock its 8th biggest position. Lagoda Investment Management L.P. owned about 4.87% of Stereotaxis worth $9,408,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in STXS. Two Sigma Securities LLC bought a new position in shares of Stereotaxis in the fourth quarter worth approximately $54,000. SG Americas Securities LLC grew its stake in Stereotaxis by 39.2% in the 4th quarter. SG Americas Securities LLC now owns 26,360 shares of the company's stock worth $60,000 after buying an additional 7,417 shares in the last quarter. Jane Street Group LLC increased its holdings in shares of Stereotaxis by 26.9% in the 3rd quarter. Jane Street Group LLC now owns 29,773 shares of the company's stock worth $61,000 after buying an additional 6,313 shares during the last quarter. Wells Fargo & Company MN increased its holdings in shares of Stereotaxis by 53.7% in the 4th quarter. Wells Fargo & Company MN now owns 26,915 shares of the company's stock worth $61,000 after buying an additional 9,403 shares during the last quarter. Finally, Hsbc Holdings PLC raised its position in shares of Stereotaxis by 102.6% during the 4th quarter. Hsbc Holdings PLC now owns 42,581 shares of the company's stock valued at $97,000 after buying an additional 21,563 shares in the last quarter. 45.35% of the stock is currently owned by hedge funds and other institutional investors.

Stereotaxis Trading Up 0.5%

Shares of STXS stock traded up $0.01 during trading hours on Thursday, hitting $2.05. 213,024 shares of the company's stock were exchanged, compared to its average volume of 366,702. The company has a market capitalization of $173.70 million, a PE ratio of -7.32 and a beta of 1.54. Stereotaxis, Inc. has a 12-month low of $1.54 and a 12-month high of $2.72. The business's 50 day simple moving average is $1.88 and its 200-day simple moving average is $2.07.

Insider Activity at Stereotaxis

In related news, Director Paul J. Isaac acquired 38,000 shares of the company's stock in a transaction dated Monday, March 10th. The stock was purchased at an average price of $1.81 per share, with a total value of $68,780.00. Following the completion of the purchase, the director now owns 87,299 shares in the company, valued at $158,011.19. This trade represents a 77.08% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 18.52% of the stock is owned by insiders.

Stereotaxis Company Profile

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. Its robotic magnetic navigation (RMN) systems include the Genesis RMN and Niobe systems, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites.